IMET will be fast-tracked. The FDA cannot come to any other conclusion, considering its safety, effectiveness and potential.
Whatever bumps in the road that are encountered, the JNJ partnership and IMET medical successes are and will be the dominant factors.
This stock has no choice, but to go up. I keep repeating myself. We have had 3 very impressive conferences (Stifel, Piper Jaffray, ASH) in recent weeks exploring the successes and potential of IMET with new partners, FDA blessings, and NO NEGATIVE NEWS.
There is nothing left to keep the PPS down: great medicine, great partners, deep pockets, great potential. The trend is upward, and the pattern is unpredictable.
Look at Slide # 12. That is a quick summary of the good news.
JNJ has a key building block in finding a cure for cancer, and they know it. Next year we will see more combinations with IMET. The combination with an Amgen medicine was particular impressive, claiming to increase the power of IMET by a factor of 4 (not in humans).
It looks like "history" has been delayed by one year, primarily by the inopportune FDA holds, and the ability of shorts and hedge funds to take advantage of them. The JNJ partnership should correct all of those problems, especially since all holds have been lifted. ASH is here and Dr. Tefferi's presentation is tomorrow. At 7 PM we will get Dr. Scarlett's review of recent events, plus the Australian inputs.
It looks like "history" has been delayed by one year, primarily by the inopportune FDA holds, and the ability of shorts and hedge funds to take advantage of them. The JNJ partnership should correct all of those problems, especially since all holds have been lifted.
I think the shorts and hedge funds have met their match, and the PPS will explode to the upside. This is a fundamental building block in finding a cure for cancer (Tantamount to a Cure). A CURE FOR CANCER!!!
$3.64 close is the tip of the iceberg. Next week will be "interesting".
There will be 5 IMET presentations at ASH, led by Dr. Tefferi on Dec. 8. JNJ (Janssen Biotech) plus Mayo Clinic have allied with Geron to form a very powerful oncology program (telomeres-telomerase-genetics) that is "Tantamount to a Cure" (from Mayo Clinic). This stock is about to "takeoff".
The "PPS-Surprise" is just around the corner. The JNJ partnership plus Mayo Clinic is a very powerful combination, that is also very honest and very believable.
It seems to me that the future of IMET is guaranteed by the Janssen/JNJ relationship. There have been only positive presentations from Stifel and Piper-Jaffray. I expect more good news from ASH. Cancer-Cure is being redefined by IMET with the combination science of telomeres-telomerase-genetics on a steep learning curve.
Perhaps someone will ask him what "Tantamount to a Cure" is suppose to mean. If it means, by dictionary definition, equivalent to a cure, then the stock has been held down by artificial means (short-hedge-funds) and long term investors have already won, somewhat belatedly.
IMET has gone further than any other medicine, that I know about, in bringing forth the possibility of a cancer cure at some level. The "holy grail" seems to be imbedded in cancer stemcells, that seem to be able to survive in the blood, well after remissions have occurred. There is a relation between telomeres, telomerase and cancer stemcells that will be at the core of future research. "Tantamount to a Cure" means to me, that a cure is possible, but we must get the cancer stemcells for the cure to be complete. Perhaps IMET has that capability in some cases.
"I'm looking for IMET's unique action against the cancer stem cells to prevent this."--from rx7171
Of course this would be the ultimate miracle, and an area for some intense research. Do animal studies suggest this level of a cure?
Dr. Tefferi will be presenting at ASH (Dec.8). Some people are talking about IMET as a cure for cancer. IMET looks very promising, but is it a cure? What is the role of genetics, since some people appear to be cured, some are in remission, and some do not seem to benefit? Does early detection and IMET treatment bring about many more cures (compare to Ebola for early treatment)?
ASH hopefully will define, "Tantamount to a Cure" (from Mayo Clinic brochure & Dr. Tefferi) in some cases. Are we talking about true-cures or the possibility and potential of cures, that have not happened yet? Tantamount can mean the same-as, near-to, or looks-like, which are similar definitions, but also can be very different. Remissions and cures are not the same.
All cures are remissions, but not all remissions are cures. I suspect IMET has not been around long enough to tell if cures are possible in MF. Certainly, long term remissions can be nearly as good as cures, especially if they can be maintained indefinitely (chronic perhaps, with IMET maintenance).
All cures are remissions, but not all remissions are cures. I suspect Imetelstat has not been around long enough to tell if cures are possible in MF. Certainly, long term remissions are nearly as good as cures, if they can be maintained indefinitely (chronic perhaps, with IMET maintenance).